Live Breaking Biotech News and Articles

Biotech News Journal

Subscribe to Biotech News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Biotech News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Latest News from Biotech News Journal
THOUSAND OAKS, Calif., Aug. 27, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the U.S. Food and Drug Administration (FDA) has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF). Ivabradine is an oral drug that inhibits the If ...
NEW YORK, Aug. 27, 2014 /PRNewswire/ -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of veteran equity analyst Charles "Tony" Butler as a managing director and senior equity analyst. Mr. Butler will focus ...
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the Citi 2014 G...
NEW YORK, Aug. 27, 2014 /PRNewswire-USNewswire/ -- The market for test and pharmaceutical pairs, known as companion diagnostics in the testing industry, has grown significantly. The global companion diagnostic market is valued at about $1.2 billion for 2013.  This is up from $950 milli...
DALLAS, August 27, 2014 /PRNewswire/ --
DALLAS, August 27, 2014 /PRNewswire/ --
DALLAS, August 27, 2014 /PRNewswire/ --
SEATTLE, Aug. 27, 2014 /PRNewswire-USNewswire/ -- ARCH Venture Partners, one of the largest U.S. technology venture firms investing in the development of seed and early-stage advanced technology companies, today announced that its eighth venture fund closed with more than $400 million ...
DALLAS, August 27, 2014 /PRNewswire/ --
DALLAS, Aug. 27, 2014 /PRNewswire-iReach/ -- "Fatty Liver Disease Global Clinical Trials Review, H2, 2014″ provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It in...
ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will m...
DUBLIN, Aug. 27, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Biodegradable Plastics Industry Report 2014" report to their offering.
WASHINGTON, NEW YORK and LONDON, Aug. 27, 2014 /PRNewswire/ -- As a leading provider of market research solutions, MarketResearch.com is pleased to announce the addition of new content to its Kalorama Information Medical Devices Knowledge Center.
Cambrian Innovation, a water and bioenergy technology provider today announced that it has been named a 2015 Technology Pioneer by the World Economic Forum. Cambrian Innovation is the only company with a solution for the growing global water crisis ...
SAN DIEGO, CA--(Marketwired - August 26, 2014) - Targazyme, Inc. (formerly America Stem Cell, Inc.), a clinical-stage biopharmaceutical company developing novel enzyme technologies and products to improve efficacy outcomes for cancer immunotherapy and cell therapy, announced today the ...
Knowles Corporation (NYSE: KN) has committed $100,000 to the University of Illinois at Chicago (UIC) College of Engineering to support female engineering students. Knowles, a Chicago company and the market leader and global supplier of advanced micro-acousti...
ROCKVILLE, Md., Aug. 26, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of a new lease with GlycoMimetics, Inc. (NASDAQ: GLYC) for one building comprising approximately 33,800 square feet at the Center for Life Science | Shady Grove in Rockville,...
DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Glucose Meter Industry Report 2014 " report to their offering.
DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Glucose Meter Industry Report 2014 " report to their offering.
NEW YORK and POINT ROBERTS, Washington, August 26, 2014 /PRNewswire/ --
NEW YORK and POINT ROBERTS, Washington, August 26, 2014 /PRNewswire/ --
DALLAS, August 26, 2014 /PRNewswire/ --
DALLAS, August 26, 2014 /PRNewswire/ --
GAITHERSBURG, Md., Aug. 26, 2014 /PRNewswire -- Clongen Laboratories, celebrating its tenth anniversary, is a leading provider of diagnostic and contract research services.  The company announced new test offerings to detect and identify emerging pathogens most recently implicated in s...
DALLAS, August 26, 2014 /PRNewswire/ --
DALLAS, August 26, 2014 /PRNewswire/ --
Meredian Inc., MHG, leading biopolymer manufacturer, is on the brink of a significant expansion. As previously announced, their PHA has already reached several achievements in the industry including the affirmation of scalability of production by global prov...
DALLAS, August 26, 2014 /PRNewswire/ --
DALLAS, August 26, 2014 /PRNewswire/ --
ALPHARETTA, Ga., Aug. 26, 2014 /PRNewswire/ -- ViveBio, LLC a leading provider of products for ambient biological sample collection, stabilization and transportation, announced today that it has signed a distribution agreement with Laboratory Procurement Services, LLC (LPS) of Knoxvill...
Panther Biotechnology, Inc. (OTCQB: PBYA) announced today the appointments of Mr. David Barshis and Mr. James Sapirstein to the company's Board of Directors. In addition the Panther announced it has secured an option agreement on a license for its lead technology, Numonafide a potentia...
DALLAS, August 26, 2014 /PRNewswire/ --
DALLAS, August 26, 2014 /PRNewswire/ --
Stevia First Corp. (OTCQB: STVF) ("Stevia First" or the "Company"), an agricultural biotechnology company based in California's Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming th...
iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, today announced it has entered into a common stock purchase agreement with Aspire Capital Fund, LLC. Within two business days of approval of the transactio...